𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Efficacy of parvaquone and long-acting oxytetracycline in Theileria annulata infection

✍ Scribed by G.C. Bansal; S.P. Sharma

Publisher
Elsevier Science
Year
1986
Tongue
English
Weight
251 KB
Volume
21
Category
Article
ISSN
0304-4017

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Long-term safety and efficacy of long-ac
Long-term safety and efficacy of long-acting risperidone in elderly psychotic patients
✍ Werner Kissling; Per Glue; Rossella Medori; Steve Simpson 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 144 KB 👁 1 views

## Abstract This subgroup analysis of the 6‐month, open‐label Switch to Risperidone Microspheres (StoRMi) trial evaluated long‐term safety and efficacy of a direct conversion to risperidone long‐acting injectable (RLAI) in 52 elderly patients (≥65 years) with psychosis stabilized on oral or depot a

Parasite-accessory cell interactions in
Parasite-accessory cell interactions in Theileriosis. Antigen presentation by Theileria annulata-infected macrophages and production of continuously growing antigen-presenting cell lines
✍ Elizabeth J. Glass; Roger L. Spooner 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 727 KB

Parasite-accessory cell interactions in Theileriosis. Antigen mesentation bv Theileria annulata-0 1 . I infected macrophages and production of Edinburgh Research Station, ~o s l i n continuously growing antigen-presenting cell lines

Long-term tolerability and efficacy of c
Long-term tolerability and efficacy of cabergoline, a new long-acting dopamine agonist, in Parkinson's disease
✍ R. Inzelberg; P. Nisipeanu; M. J. Rabey; Prof. A. D. Korczyn 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 333 KB 👁 2 views

## Abstract Motor fluctuations constitute a severe complication of chronic levodopa therapy. The addition of dopamine agonists may partially alleviate these responses; however, due to the short half‐lefe of these drugs, several daily doses are required. Cabergoline is a new dopamine agonist with a

Efficacy and safety of long-acting rispe
Efficacy and safety of long-acting risperidone in elderly patients with schizophrenia and schizoaffective disorder
✍ Robert A. Lasser; Cynthia A. Bossie; Young Zhu; Georges Gharabawi; Mariëlle Eerd 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 93 KB 👁 2 views

## Abstract ## Background Elderly patients are often an underserved population in terms of optimizing treatment outcomes. Long‐acting risperidone, the first long‐acting injectable atypical antipsychotic, can improve outcomes through continuous medication delivery. ## Objective To assess the effi